2026-06-23T08:24:58-07:00 2025-08-31 990 2024-09-01 203674498 GLOBAL HEALTH SOLUTIONS INC GLOB 4045921430 330 W Ponce de Leon Ave Decatur GA 300303001 Ellen Wild Chief Operating Officer 4046875607 2026-03-31 1 2024 2025-03-06 01:10:19Z Patrick O'Carroll 330 Ponce de Leon Avenue Decatur GA 30030 772045614 0 X www.taskforce.org X 2005 GA As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc. 4 0 0 0 0 0 511468181 772045614 0 0 0 0 0 0 511468181 772045614 511468181 772045614 0 0 0 0 0 0 0 0 0 511468181 772045614 0 0 0 0 0 0 0 0 X As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases. 0 0 758274549 758274549 758274549 The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2024 and August 2025, ITI organized just-in-time shipments of 44.6 million treatments for trachoma to be distributed at MDAs in 12 countries. As of August 2025, ITI has shipped more than 1.117 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 4,136 surveys across 55 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.5 billion people in 2002 to 97.1 million in November 2025 according to the World Health Organization (WHO). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality. In addition to ITI's work in trachoma, ITI was awarded a grant from the Gates Foundation in August 2024 to expand into the donation of azithromycin for child survival. Between September 2024 and August 2025, ITI organized just-in-time shipments of 22.8 million treatments for child survival to be distributed at MDAs in 3 countries. 13771065 13771065 13771065 Mectizan Donation Program In 2025, 349.1 million treatments were approved for mass drug administration (MDA) for onchocerciasis and lymphatic filariasis (LF) elimination in 36 countries and territories. The breakdown of treatments approved is as follows: 1) 240.9 million for onchocerciasis only including 30.6 million treatments approved to implement a second round of treatment in 8 countries (Brazil, Burkina Faso, DRC, Ethiopia, Malawi, Togo, Uganda and Venezuela). 2) 29.9 million for onchocerciasis & LF co-endemic communities. 3) 78.3 million for LF only, of which 51.4 million were approved for 11 countries and territories implementing triple therapy with ivermectin, DEC, and albendazole (IDA). The number of treatments approved in 2025 decreased compared with previous years. This decline is not only attributable to the downscaling of the LF programme, but also to the decision to implement only a single treatment round for onchocerciasis instead of two in Ghana, Tanzania, and Togo, following USAID-NTD funding cuts and a missed campaign in Mozambique and Angola. 2025, total shipments were down to 737.6 million tablets. This decrease was driven not only by the large number of tablets remaining in inventory after the 2024 annual mass drug administrations (MDAs) in countries (138.4 million tablets), but also by the deferral to 2026 of 179.7 million tablets originally scheduled for shipment in 2025 due to operational challenges in Nigeria, the Democratic Republic of the Congo, Mali, Sudan, and the Philippines By the end of 2025, cumulative shipments of Mectizan 3 mg tablets reached 14.66 billion, representing 5.23 billion treatments since the programme began in 1987. The milestone of 5 billion treatments was celebrated throughout the year. 0 0 0 772045614 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 4 0 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 GA X Daniel N Martins 4046875620 330 W Ponce de Leon Ave Decatur GA 300303001 Patrick O'Carroll Chairman 1 39 X 0 397023 0 Mark McKinlay Officer 0 40 X 0 245812 0 Ellen Wild Treasurer 1 39 X 0 237534 0 Daniel N Martins Secretary 1 39 X 0 228252 0 Nancy Knight Officer 1 39 X 0 198758 0 0 1307379 0 0 1 1 0 0 0 0 0 0 772045614 772045614 772045614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 772045614 0 0 0 0 0 0 0 772045614 772045614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 772045614 772045614 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 0 1 X 1 1 1 X X X 1 THE TASK FORCE FOR GLOBAL HEALTH INC Type I 581698648 7 1 0 772045614 1 0 772045614 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 Central America and the Caribbean 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 373695 East Asia and the Pacific 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 37800 Middle East and North Africa 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 811755 South America 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 296415 South Asia 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 4277385 Sub-Saharan Africa 0 0 Program Services Donation of mectizan drug for the treatment of onchocerciasis (river blindness) 7974015 East Asia and the Pacific 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma 2015309 South Asia 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma 732410 Sub-Saharan Africa 0 0 Program Services Donation of zithromax drug for the treatment of blinding trachoma 755526830 0 0 772045614 Central America and the Caribbean For the treatment of river blindness in Haiti 0 0 373695 Donated drug - Mectizan Lower of market or cost East Asia and the Pacific For the treatment of river blindness in Brunei 0 N/A 6300 Drug donation - Mectizan Lower of market or cost East Asia and the Pacific For the treatment of river blindness in Malaysia 0 N/A 10290 Drug donated - Mectizan Lower of cost or market value East Asia and the Pacific For the treatment of river blindness in Polynesie France 0 N/A 19425 Drug donation - Mectizan Lower of cost or market value Middle East and North Africa For treament of river blindness in Yemen 0 N/A 811755 Donated drug - Mectizan Lower of cost or market value South America For treament of river blindness in Guyana 0 N/A 296415 Donated drug - Mectizan Lower of cost or market value South Asia For treament of river blindness in India 0 N/A 4276860 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in Angola 0 N/A 2316615 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in DRC 0 N/A 1195635 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in Guinea 0 N/A 181125 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in Madagascar 0 N/A 2761080 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in Tanzania 0 N/A 1059870 Donated drug - Mectizan Lower of cost or market value Sub-Saharan Africa For treament of river blindness in Zimbabwe 0 N/A 459690 Donated drug - Mectizan Lower of cost or market value East Asia and the Pacific For treament of blinding trachoma in Kiribati 0 N/A 2015309 Donated drug - Zithromax Lower of cost or market value South Asia For treament of blinding trachoma in Afghanistan 0 N/A 732410 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Central African Republic 0 N/A 18441927 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Democratic Republic of Congo 0 N/A 25133401 Donated drug - Zithromax Donated drug - Zithromax Sub-Saharan Africa For treament of blinding trachoma in Ethiopia 0 N/A 506320803 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Mozambique 0 N/A 7663487 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Niger 0 N/A 13072453 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Kiribati 0 N/A 42652130 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in South Sudan 0 N/A 21377664 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Sudan 0 N/A 9129552 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Tanzania 0 N/A 7640440 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Zimbabwe 0 N/A 8587905 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Mali 0 N/A 23362517 Donated drug - Zithromax Lower of cost or market value Sub-Saharan Africa For treament of blinding trachoma in Nigeria 0 N/A 72144551 Donated drug - Zithromax Lower of cost or market value 27 2 0 0 0 0 0 1 Schedule F, Part I, Line 2 The In-Kind Contributions are shipped directly by the donors to the countries where they are needed. Global Health Solutions obtains the shipping documents for processing in the accounting system. Occasional site visits are carried out in some countries to assess and evaluate the impact of the program activities. In our Ethiopia country office, an audit firm is appointed to ensure that things are done in compliance to required rules and regulations. 0 0 0 0 0 0 0 0 0 Patrick O'Carroll Chairman 0 397023 0 0 0 0 0 31050 0 1323 0 429396 0 0 Mark McKinlay Program Director 0 245812 0 0 0 0 0 22952 0 44090 0 312854 0 0 Daniel N Martins Secretary 0 191560 0 10039 0 26653 0 17608 0 40239 0 286099 0 0 Ellen Wild Treasurer 0 237534 0 0 0 0 0 21510 0 1223 0 260267 0 0 Nancy Knight Officer 0 198758 0 0 0 0 0 0 0 26 0 198784 0 0 Schedule J, Part I, Line 3 The organization does not have employees but has officers who are paid by the related organization. X 3 772045614 Lower of market or donor's cost 0 1 1 Schedule M, Part I, Line 32b Donated drugs are shipped by third parties Form 990, Part III, Line 2 The organization started a new drug donation program funded by the Gates Foundation during the tax year. Form 990, Part VI, Section B, Line 11b Once Form 990 is completed, it is emailed as a pdf file to each board member and officers for their review and comments. They are required to notify the organization with any issues or concerns they may have. Form 990, Part VI, Section B, Line 12c The organization does not have employees but has officers. At the end of every fiscal year, all officers are required to read and sign all relevant policies. Form 990, Part VI, Section C, Line 19 The financial information for three fiscal years is available on the organization's website together with its Form 990 reports and conflict of interest policy. The Task Force for Global Health Inc 330 W Ponce de Leon Ave Decatur GA 30030 581698648 Management and distribution of donated medicines GA 501(c)(3) 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 The Task Force for Global Health Inc o 0 There is no allocation of payroll cost to the Supporting Organization The Task Force for Global Health Inc n 0 There is no cost allocation with the Supporting Organization.